Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 3757 to 3765 of 3765 entries
Sorted by: Best Match Show Resources per page
Progression of Frailty in Survivors of Childhood Cancer: A St. Jude Lifetime Cohort Report.

Journal of the National Cancer Institute

Delaney A, Howell CR, Krull KR, Brinkman TM, Armstrong GT, Chemaitilly W, Wilson CL, Mulrooney DA, Wang Z, Lanctot JQ, Johnson RE, Krull MR, Partin RE, Shelton KC, Srivastava DK, Robison LL, Hudson MM, Ness KK.
PMID: 33720359
J Natl Cancer Inst. 2021 Oct 01;113(10):1415-1421. doi: 10.1093/jnci/djab033.

BACKGROUND: Some adult survivors of childhood cancers develop frailty at higher rates than expected based on their chronological age. This study examined the incidence of frailty among survivors at 10 or more years after diagnosis, frailty prevalence 5 years...

Cite
Delaney A, Howell CR, Krull KR, et al. Progression of Frailty in Survivors of Childhood Cancer: A St. Jude Lifetime Cohort Report. J Natl Cancer Inst. 2021;113(10):1415-1421doi: 10.1093/jnci/djab033.
Delaney, A., Howell, C. R., Krull, K. R., Brinkman, T. M., Armstrong, G. T., Chemaitilly, W., Wilson, C. L., Mulrooney, D. A., Wang, Z., Lanctot, J. Q., Johnson, R. E., Krull, M. R., Partin, R. E., Shelton, K. C., Srivastava, D. K., Robison, L. L., Hudson, M. M., & Ness, K. K. (2021). Progression of Frailty in Survivors of Childhood Cancer: A St. Jude Lifetime Cohort Report. Journal of the National Cancer Institute, 113(10), 1415-1421. https://doi.org/10.1093/jnci/djab033
Delaney, Angela, et al. "Progression of Frailty in Survivors of Childhood Cancer: A St. Jude Lifetime Cohort Report." Journal of the National Cancer Institute vol. 113,10 (2021): 1415-1421. doi: https://doi.org/10.1093/jnci/djab033
Delaney A, Howell CR, Krull KR, Brinkman TM, Armstrong GT, Chemaitilly W, Wilson CL, Mulrooney DA, Wang Z, Lanctot JQ, Johnson RE, Krull MR, Partin RE, Shelton KC, Srivastava DK, Robison LL, Hudson MM, Ness KK. Progression of Frailty in Survivors of Childhood Cancer: A St. Jude Lifetime Cohort Report. J Natl Cancer Inst. 2021 Oct 01;113(10):1415-1421. doi: 10.1093/jnci/djab033. PMID: 33720359; PMCID: PMC8633430.
Copy Download .nbib Format: NLM
Association Between Surgical Volume and Survival Among Patients With Variant Histologies of Bladder Cancer.

Urology

Sui W, Hall ME, Barocas DA, Chang SS, Luckenbaugh AN, Moses KA, Penson DF, Wallis CJD, Laviana AA.
PMID: 34606878
Urology. 2022 Jan;159:100-106. doi: 10.1016/j.urology.2021.09.009. Epub 2021 Oct 01.

OBJECTIVE: To examine the relationship between hospital volume and the management of bladder cancer variant histology. Variant histologies of bladder cancer are rare which limits the ability for providers to develop expertise however there is a clear hospital and/or...

Cite
Sui W, Hall ME, Barocas DA, et al. Association Between Surgical Volume and Survival Among Patients With Variant Histologies of Bladder Cancer. Urology. 2021;159:100-106doi: 10.1016/j.urology.2021.09.009.
Sui, W., Hall, M. E., Barocas, D. A., Chang, S. S., Luckenbaugh, A. N., Moses, K. A., Penson, D. F., Wallis, C. J. D., & Laviana, A. A. (2022). Association Between Surgical Volume and Survival Among Patients With Variant Histologies of Bladder Cancer. Urology, 159100-106. https://doi.org/10.1016/j.urology.2021.09.009
Sui, Wilson, et al. "Association Between Surgical Volume and Survival Among Patients With Variant Histologies of Bladder Cancer." Urology vol. 159 (2022): 100-106. doi: https://doi.org/10.1016/j.urology.2021.09.009
Sui W, Hall ME, Barocas DA, Chang SS, Luckenbaugh AN, Moses KA, Penson DF, Wallis CJD, Laviana AA. Association Between Surgical Volume and Survival Among Patients With Variant Histologies of Bladder Cancer. Urology. 2022 Jan;159:100-106. doi: 10.1016/j.urology.2021.09.009. Epub 2021 Oct 01. PMID: 34606878.
Copy Download .nbib Format: NLM
Myokine Expression and Tumor-Suppressive Effect of Serum after 12 wk of Exercise in Prostate Cancer Patients on ADT.

Medicine and science in sports and exercise

Kim JS, Wilson RL, Taaffe DR, Galvão DA, Gray E, Newton RU.
PMID: 34559721
Med Sci Sports Exerc. 2022 Feb 01;54(2):197-205. doi: 10.1249/MSS.0000000000002783.

PURPOSE: Although several mechanisms have been proposed for the tumor-suppressive effect of exercise, little attention has been given to myokines, even though skeletal muscle is heavily recruited during exercise resulting in myokine surges. We measured resting serum myokine levels...

Cite
Kim JS, Wilson RL, Taaffe DR, et al. Myokine Expression and Tumor-Suppressive Effect of Serum after 12 wk of Exercise in Prostate Cancer Patients on ADT. Med Sci Sports Exerc. 2022;54(2):197-205doi: 10.1249/MSS.0000000000002783.
Kim, J. S., Wilson, R. L., Taaffe, D. R., Galvão, D. A., Gray, E., & Newton, R. U. (2022). Myokine Expression and Tumor-Suppressive Effect of Serum after 12 wk of Exercise in Prostate Cancer Patients on ADT. Medicine and science in sports and exercise, 54(2), 197-205. https://doi.org/10.1249/MSS.0000000000002783
Kim, Jin-Soo, et al. "Myokine Expression and Tumor-Suppressive Effect of Serum after 12 wk of Exercise in Prostate Cancer Patients on ADT." Medicine and science in sports and exercise vol. 54,2 (2022): 197-205. doi: https://doi.org/10.1249/MSS.0000000000002783
Kim JS, Wilson RL, Taaffe DR, Galvão DA, Gray E, Newton RU. Myokine Expression and Tumor-Suppressive Effect of Serum after 12 wk of Exercise in Prostate Cancer Patients on ADT. Med Sci Sports Exerc. 2022 Feb 01;54(2):197-205. doi: 10.1249/MSS.0000000000002783. PMID: 34559721.
Copy Download .nbib Format: NLM
Cardiac-derived TGF-β1 confers resistance to diet-induced obesity through the regulation of adipocyte size and function.

Molecular metabolism

Longenecker JZ, Petrosino JM, Martens CR, Hinger SA, Royer CJ, Dorn LE, Branch DA, Serrano J, Stanford KI, Kyriazis GA, Baskin KK, Accornero F.
PMID: 34583010
Mol Metab. 2021 Dec;54:101343. doi: 10.1016/j.molmet.2021.101343. Epub 2021 Sep 25.

Regulation of organismal homeostasis in response to nutrient availability is a vital physiological process that involves inter-organ communication. Understanding the mechanisms controlling systemic cross-talk for the maintenance of metabolic health is critical to counteract diet-induced obesity. Here, we show...

Cite
Longenecker JZ, Petrosino JM, Martens CR, et al. Cardiac-derived TGF-β1 confers resistance to diet-induced obesity through the regulation of adipocyte size and function. Mol Metab. 2021;54:101343doi: 10.1016/j.molmet.2021.101343.
Longenecker, J. Z., Petrosino, J. M., Martens, C. R., Hinger, S. A., Royer, C. J., Dorn, L. E., Branch, D. A., Serrano, J., Stanford, K. I., Kyriazis, G. A., Baskin, K. K., & Accornero, F. (2021). Cardiac-derived TGF-β1 confers resistance to diet-induced obesity through the regulation of adipocyte size and function. Molecular metabolism, 54101343. https://doi.org/10.1016/j.molmet.2021.101343
Longenecker, Jacob Z, et al. "Cardiac-derived TGF-β1 confers resistance to diet-induced obesity through the regulation of adipocyte size and function." Molecular metabolism vol. 54 (2021): 101343. doi: https://doi.org/10.1016/j.molmet.2021.101343
Longenecker JZ, Petrosino JM, Martens CR, Hinger SA, Royer CJ, Dorn LE, Branch DA, Serrano J, Stanford KI, Kyriazis GA, Baskin KK, Accornero F. Cardiac-derived TGF-β1 confers resistance to diet-induced obesity through the regulation of adipocyte size and function. Mol Metab. 2021 Dec;54:101343. doi: 10.1016/j.molmet.2021.101343. Epub 2021 Sep 25. PMID: 34583010; PMCID: PMC8529557.
Copy Download .nbib Format: NLM
Radiation therapy related cardiac disease risk in childhood cancer survivors: Updated dosimetry analysis from the Childhood Cancer Survivor Study.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Shrestha S, Bates JE, Liu Q, Smith SA, Oeffinger KC, Chow EJ, Gupta AC, Owens CA, Constine LS, Hoppe BS, Leisenring WM, Qiao Y, Weathers RE, Court LE, Pinnix CC, Kry SF, Mulrooney DA, Armstrong GT, Yasui Y, Howell RM.
PMID: 34454975
Radiother Oncol. 2021 Oct;163:199-208. doi: 10.1016/j.radonc.2021.08.012. Epub 2021 Aug 26.

BACKGROUND AND PURPOSE: We previously evaluated late cardiac disease in long-term survivors in the Childhood Cancer Survivor Study (CCSS) based on heart radiation therapy (RT) doses estimated from an age-scaled phantom with a simple atlas-based heart model (HMETHODS: We...

Cite
Shrestha S, Bates JE, Liu Q, et al. Radiation therapy related cardiac disease risk in childhood cancer survivors: Updated dosimetry analysis from the Childhood Cancer Survivor Study. Radiother Oncol. 2021;163:199-208doi: 10.1016/j.radonc.2021.08.012.
Shrestha, S., Bates, J. E., Liu, Q., Smith, S. A., Oeffinger, K. C., Chow, E. J., Gupta, A. C., Owens, C. A., Constine, L. S., Hoppe, B. S., Leisenring, W. M., Qiao, Y., Weathers, R. E., Court, L. E., Pinnix, C. C., Kry, S. F., Mulrooney, D. A., Armstrong, G. T., Yasui, Y., & Howell, R. M. (2021). Radiation therapy related cardiac disease risk in childhood cancer survivors: Updated dosimetry analysis from the Childhood Cancer Survivor Study. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 163199-208. https://doi.org/10.1016/j.radonc.2021.08.012
Shrestha, Suman, et al. "Radiation therapy related cardiac disease risk in childhood cancer survivors: Updated dosimetry analysis from the Childhood Cancer Survivor Study." Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology vol. 163 (2021): 199-208. doi: https://doi.org/10.1016/j.radonc.2021.08.012
Shrestha S, Bates JE, Liu Q, Smith SA, Oeffinger KC, Chow EJ, Gupta AC, Owens CA, Constine LS, Hoppe BS, Leisenring WM, Qiao Y, Weathers RE, Court LE, Pinnix CC, Kry SF, Mulrooney DA, Armstrong GT, Yasui Y, Howell RM. Radiation therapy related cardiac disease risk in childhood cancer survivors: Updated dosimetry analysis from the Childhood Cancer Survivor Study. Radiother Oncol. 2021 Oct;163:199-208. doi: 10.1016/j.radonc.2021.08.012. Epub 2021 Aug 26. PMID: 34454975.
Copy Download .nbib Format: NLM
Metabolic and inflammatory risk reduction in response to lipid-lowering and lifestyle modification in the medically underserved individuals.

American journal of preventive cardiology

Chu MP, Many G, Isquith DA, McKeeth S, Williamson J, Neradilek MB, Colletti P, Zhao XQ.
PMID: 34401861
Am J Prev Cardiol. 2021 Jul 31;7:100227. doi: 10.1016/j.ajpc.2021.100227. eCollection 2021 Sep.

INTRODUCTION: Medically underserved (US) populations have an increased level of atherosclerotic cardiovascular disease (ASCVD) risk, however, few studies investigated ASCVD risk reduction in US.METHODS: Of 217 subjects with ApoB ≥120 mg/dL and carotid atherosclerosis (≥15% stenosis by ultrasound) enrolled...

Cite
Chu MP, Many G, Isquith DA, et al. Metabolic and inflammatory risk reduction in response to lipid-lowering and lifestyle modification in the medically underserved individuals. Am J Prev Cardiol. 2021;7:100227doi: 10.1016/j.ajpc.2021.100227.
Chu, M. P., Many, G., Isquith, D. A., McKeeth, S., Williamson, J., Neradilek, M. B., Colletti, P., & Zhao, X. Q. (2021). Metabolic and inflammatory risk reduction in response to lipid-lowering and lifestyle modification in the medically underserved individuals. American journal of preventive cardiology, 7100227. https://doi.org/10.1016/j.ajpc.2021.100227
Chu, Michael P, et al. "Metabolic and inflammatory risk reduction in response to lipid-lowering and lifestyle modification in the medically underserved individuals." American journal of preventive cardiology vol. 7 (2021): 100227. doi: https://doi.org/10.1016/j.ajpc.2021.100227
Chu MP, Many G, Isquith DA, McKeeth S, Williamson J, Neradilek MB, Colletti P, Zhao XQ. Metabolic and inflammatory risk reduction in response to lipid-lowering and lifestyle modification in the medically underserved individuals. Am J Prev Cardiol. 2021 Jul 31;7:100227. doi: 10.1016/j.ajpc.2021.100227. eCollection 2021 Sep. PMID: 34401861; PMCID: PMC8358155.
Copy Download .nbib Format: NLM
Neoadjuvant Selicrelumab, an Agonist CD40 Antibody, Induces Changes in the Tumor Microenvironment in Patients with Resectable Pancreatic Cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research

Byrne KT, Betts CB, Mick R, Sivagnanam S, Bajor DL, Laheru DA, Chiorean EG, O'Hara MH, Liudahl SM, Newcomb C, Alanio C, Ferreira AP, Park BS, Ohtani T, Huffman AP, Väyrynen SA, Dias Costa A, Kaiser JC, Lacroix AM, Redlinger C, Stern M, Nowak JA, Wherry EJ, Cheever MA, Wolpin BM, Furth EE, Jaffee EM, Coussens LM, Vonderheide RH.
PMID: 34112709
Clin Cancer Res. 2021 Aug 15;27(16):4574-4586. doi: 10.1158/1078-0432.CCR-21-1047. Epub 2021 Jun 10.

PURPOSE: CD40 activation is a novel clinical opportunity for cancer immunotherapy. Despite numerous active clinical trials with agonistic CD40 monoclonal antibodies (mAb), biological effects and treatment-related modulation of the tumor microenvironment (TME) remain poorly understood.PATIENTS AND METHODS: Here, we...

Cite
Byrne KT, Betts CB, Mick R, et al. Neoadjuvant Selicrelumab, an Agonist CD40 Antibody, Induces Changes in the Tumor Microenvironment in Patients with Resectable Pancreatic Cancer. Clin Cancer Res. 2021;27(16):4574-4586doi: 10.1158/1078-0432.CCR-21-1047.
Byrne, K. T., Betts, C. B., Mick, R., Sivagnanam, S., Bajor, D. L., Laheru, D. A., Chiorean, E. G., O'Hara, M. H., Liudahl, S. M., Newcomb, C., Alanio, C., Ferreira, A. P., Park, B. S., Ohtani, T., Huffman, A. P., Väyrynen, S. A., Dias Costa, A., Kaiser, J. C., Lacroix, A. M., Redlinger, C., Stern, M., Nowak, J. A., Wherry, E. J., Cheever, M. A., Wolpin, B. M., Furth, E. E., Jaffee, E. M., Coussens, L. M., & Vonderheide, R. H. (2021). Neoadjuvant Selicrelumab, an Agonist CD40 Antibody, Induces Changes in the Tumor Microenvironment in Patients with Resectable Pancreatic Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 27(16), 4574-4586. https://doi.org/10.1158/1078-0432.CCR-21-1047
Byrne, Katelyn T, et al. "Neoadjuvant Selicrelumab, an Agonist CD40 Antibody, Induces Changes in the Tumor Microenvironment in Patients with Resectable Pancreatic Cancer." Clinical cancer research : an official journal of the American Association for Cancer Research vol. 27,16 (2021): 4574-4586. doi: https://doi.org/10.1158/1078-0432.CCR-21-1047
Byrne KT, Betts CB, Mick R, Sivagnanam S, Bajor DL, Laheru DA, Chiorean EG, O'Hara MH, Liudahl SM, Newcomb C, Alanio C, Ferreira AP, Park BS, Ohtani T, Huffman AP, Väyrynen SA, Dias Costa A, Kaiser JC, Lacroix AM, Redlinger C, Stern M, Nowak JA, Wherry EJ, Cheever MA, Wolpin BM, Furth EE, Jaffee EM, Coussens LM, Vonderheide RH. Neoadjuvant Selicrelumab, an Agonist CD40 Antibody, Induces Changes in the Tumor Microenvironment in Patients with Resectable Pancreatic Cancer. Clin Cancer Res. 2021 Aug 15;27(16):4574-4586. doi: 10.1158/1078-0432.CCR-21-1047. Epub 2021 Jun 10. PMID: 34112709; PMCID: PMC8667686.
Copy Download .nbib Format: NLM
Supporting diversity in science through social networking.

Guerrero-Medina Giovanna, Feliú-Mójer Mónica, González-Espada Wilson, Díaz-Muñoz Greetchen, López Marcos, Díaz-Muñoz SamuelL, Fortis-Santiago Yaihara, Flores-Otero Jacqueline, Craig David, Colón-Ramos DanielA.
UIID-AD: 1748
2013;11. doi: 10.1371/journal.pbio.1001740.

The current article highlights science is disproportionately produced at research centers within a few select regions. This distribution contributes to "brain drain"—the cultural and geographical separation of researchers from their communities of origin. In places lacking research centers, brain...

Cite
Guerrero-Medina Giovanna, Feliú-Mójer Mónica, González-Espada Wilson, et al. Supporting diversity in science through social networking. 2013;11doi: 10.1371/journal.pbio.1001740.
Guerrero-Medina, G. i. o. v. a. n. n. a., Feliú-Mójer, M. �. �. �. �. n. i. c. a., González-Espada, W. i. l. s. o. n., Díaz-Muñoz, G. r. e. e. t. c. h. e. n., López, M. a. r. c. o. s., Díaz-Muñoz, S. a. m. u. e. l. L., Fortis-Santiago, Y. a. i. h. a. r. a., Flores-Otero, J. a. c. q. u. e. l. i. n. e., Craig, D. a. v. i. d., & Colón-Ramos, D. a. n. i. e. l. A. (2013). Supporting diversity in science through social networking. 11. https://doi.org/10.1371/journal.pbio.1001740
Guerrero-Medina, Giovanna, et al. "Supporting diversity in science through social networking." vol. 11 (2013). doi: https://doi.org/10.1371/journal.pbio.1001740
Guerrero-Medina Giovanna, Feliú-Mójer Mónica, González-Espada Wilson, Díaz-Muñoz Greetchen, López Marcos, Díaz-Muñoz SamuelL, Fortis-Santiago Yaihara, Flores-Otero Jacqueline, Craig David, Colón-Ramos DanielA. Supporting diversity in science through social networking. 2013;11. doi: 10.1371/journal.pbio.1001740. UIID-AD: 1748.
Copy Download .nbib Format: NLM
A workshop on leadership for MD/PhD students.

Ciampa ErinJ, Hunt AubreyA, Arneson KyleO, Mordes DanielA, Oldham WilliamM, Vin Woo Kel, Owens DavidA, Cannon MarkD, Dermody TerenceS.
UIID-AD: 60
2011;16. doi: 10.3402/meo.v16i0.7075.

Success in academic medicine requires scientific and clinical aptitude and the ability to lead a team effectively. Although combined MD/PhD training programs invest considerably in the former, they often do not provide structured educational opportunities in leadership, especially as...

Cite
Ciampa ErinJ, Hunt AubreyA, Arneson KyleO, et al. A workshop on leadership for MD/PhD students. 2011;16doi: 10.3402/meo.v16i0.7075.
Ciampa, E. r. i. n. J., Hunt, A. u. b. r. e. y. A., Arneson, K. y. l. e. O., Mordes, D. a. n. i. e. l. A., Oldham, W. i. l. l. i. a. m. M., Vin Woo, K. e. l., Owens, D. a. v. i. d. A., Cannon, M. a. r. k. D., & Dermody, T. e. r. e. n. c. e. S. (2011). A workshop on leadership for MD/PhD students. 16. https://doi.org/10.3402/meo.v16i0.7075
Ciampa, Erin J, et al. "A workshop on leadership for MD/PhD students." vol. 16 (2011). doi: https://doi.org/10.3402/meo.v16i0.7075
Ciampa ErinJ, Hunt AubreyA, Arneson KyleO, Mordes DanielA, Oldham WilliamM, Vin Woo Kel, Owens DavidA, Cannon MarkD, Dermody TerenceS. A workshop on leadership for MD/PhD students. 2011;16. doi: 10.3402/meo.v16i0.7075. UIID-AD: 60.
Copy Download .nbib Format: NLM
Showing 3757 to 3765 of 3765 entries